24248-69-9 Usage
Uses
Used in Pharmaceutical Development:
2-AMINO-6-METHYL-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID AMIDE is utilized as a key component in the development of pharmaceuticals for its ability to interact with biological targets such as enzymes and receptors. Its structural similarity to amino acids allows it to potentially modulate various biological pathways and mechanisms, offering therapeutic benefits for a variety of medical conditions.
Used in Neurological and Psychiatric Drug Development:
In the field of neurological and psychiatric drug development, 2-AMINO-6-METHYL-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID AMIDE is used as a molecular scaffold for designing drugs that can address specific disorders. Its interaction with the nervous system's biochemical processes may lead to the creation of treatments for conditions such as depression, anxiety, and other cognitive or mood-related disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 24248-69-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,2,4 and 8 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 24248-69:
(7*2)+(6*4)+(5*2)+(4*4)+(3*8)+(2*6)+(1*9)=109
109 % 10 = 9
So 24248-69-9 is a valid CAS Registry Number.
24248-69-9Relevant academic research and scientific papers
Molecular design and synthesis of 1,4-disubstituted piperazines as α1-adrenergic receptor blockers
Abou El-Ella, Dalal A.,Hussein, Mohammed M.,Serya, Rabah A.T.,Abdel Naby, Rana M.,Al-Abd, Ahmed M.,Saleh, Dalia O.,El-Eraky, Wafaa I.,Abouzid, Khaled A.M.
, p. 21 - 30 (2014/05/06)
A new series of 4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylic acid amide and 3,5,6,8-tetrahydropyrido[4′,3′:4,5]thieno[2,3-d]pyrimidin- 4-one derivatives were designed, synthesized, their binding and functional properties as α1-adrenorec
PYRAZOLEALKANAMIDE SUBSTITUTED THIOPHENES AS AMPA POTENTIATORS
-
Page/Page column 43-44, (2008/06/13)
The present invention relates to a heterocyclic derivative according to Formula (I) wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceuti
